SCHEMBL20086458

SCHEMBL20086458

CC(=O)ON1C(=O)CC(CN2C(=O)C=CC2=O)C1=O

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
BLM P54132 2/20 0.34
CYP1A2 P05177 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
WRN Q14191 1/20 0.34
HIF1A Q16665 1/20 0.34
GSK3A P49840 1/20 0.33
GSK3B P49841 1/20 0.33
MT-CO2 P00403 1/20 0.33
ALOX5 P09917 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
GMNN O75496 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
THPO P40225 1/20 0.31
PMP22 Q01453 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
MGLL Q99685 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20611006 0.79 CYP3A4 (0.35) ALDH1A1CYP1A2CYP2C19L3MBTL1MAPT
SCHEMBL3684074 0.79 CYP2C19 (0.41) CYP2C19MT-CO2ALOX5L3MBTL1
SCHEMBL24311271 0.77 MT-CO2 (0.50) MT-CO2ALOX5
SCHEMBL25046381 0.75 MT-CO2 (0.38) MT-CO2ALOX5
SCHEMBL20646637 0.73 TSHR (0.39) ALDH1A1BLMHPGDGSK3AGSK3B
SCHEMBL22561621 0.73 ATM (0.34) ALDH1A1CYP1A2CYP2C19L3MBTL1
SCHEMBL3678842 0.73 MAPT (0.33) HPGDMAPT
SCHEMBL9914761 0.71 GSK3A (0.46) ALDH1A1BLMCYP1A2HPGDCYP2C19
SCHEMBL14281129 0.71 PTGS1 (0.38) ALDH1A1BLMCYP1A2HPGDCYP2C19
SCHEMBL4326673 0.70 POLB (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001593-B2 Rigid dinitroxide biradical compounds used as improved polarizing agents for dynamic nuclear polarization techniques UNIVERSITE D'AIX-MARSEILLE (FR) 2021-05-11 US disclosed
US-10398783-B2 Antiproliferative compounds and conjugates made therefrom BRISTOL-MYERS SQUIBB COMPANY (US) 2019-09-03 US disclosed
US-20180110873-A1 ANTIPROLIFERATIVE COMPOUNDS AND CONJUGATES MADE THEREFROM BRISTOL-MYERS SQUIBB COMPANY 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180110873-A1 ANTIPROLIFERATIVE COMPOUNDS AND CONJUGATES MADE THEREFROM MKI67, HDGF, PCLAF ALDH1A1 314/4885BLM 4570/4885CYP1A2 2740/4885
US-11001593-B2 Rigid dinitroxide biradical compounds used as improved polarizing agents for dynamic nuclear polarization techniques CCNO, CCNA1, CCND1 ALDH1A1 3677/4885BLM 3628/4885CYP1A2 3261/4885
US-10398783-B2 Antiproliferative compounds and conjugates made therefrom MKI67, HDGF, PCLAF ALDH1A1 314/4885BLM 4570/4885CYP1A2 2740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.